Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
Clinical trial NCT00627354 · COMPLETED
Trial details
- NCT number
- NCT00627354
- Sponsor
- Groupe D'Etude des Tumeurs Uro-Genitales
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2011-05-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.